Brief Description of Measure:
Patients determined as having prostate cancer who are currently starting or undergoing androgen deprivation therapy (ADT), for an anticipated period of 12 months or greater and who receive an initial bone density evaluation. The bone density evaluation must be prior to the start of ADT or within 3 months of the start of ADT.
Description of Issue:
The definition field of the header currently contains information that can be found in the terminology section of the eCQM.
Below is the header definition:
"Data Criteria Value Set 2.16.840.1.1137220.127.116.111.38 DEXA, Dual Energy Xray Absorptiometry, Bone Density for Urology Care contains 2 LOINC codes identifying the axial and appendicular skeleton and will meet the measure intent."
The measure developer is proposing to remove the definition related to the DEXA value set the from Definitions field as this information can be found elsewhere in the measure.
Rationale for Change:
The information can be found in the terminology section and the VSAC.